|
|
|
|
|
by acuozzo
4955 days ago
|
|
> What about the adverse affects it will have on competition against those who don't have access to the enhancement (due to physiological, economic or other reasons)? This is already a "problem". I don't think a new (potentially, safer) nootropic drug would make matters any worse. |
|